The Past Five Years for Theravance Biopharma (NASDAQ:TBPH) Investors Has Not Been Profitable

Yahoo FinanceDec 11 20:37

Theravance Biopharma to Participate in an Upcoming Investor Conference

PR NewswireNov 20 19:00

A Quick Look at Today's Ratings for Theravance Biopharma(TBPH.US), With a Forecast Between $9 to $15

Futu NewsNov 14 21:00 · Ratings

Theravance Biopharma | 10-Q: Q3 2024 Earnings Report

SECNov 14 19:11 · Announcements

Baupost's Top Q3 Trades Include Jazz Exit, New Dollar General Stake

Seeking AlphaNov 14 06:36

Theravance Biopharma Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Sales Results.

BenzingaNov 14 01:55